ARGINASE INHIBITORS AND METHODS OF USE
Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases. L'invention concerne des composés de formule I...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LU, Min PALANI, Anandan PALTE, Rachel ACHAB, Abdelghani Abe SLOMAN, David CHILDERS, Matthew ZHANG, Hongjun PU, Qinglin FISCHER, Christian GATHIAKA, Symon LI, Derun |
| description | Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.
L'invention concerne des composés de formule I ou un sel pharmaceutiquement acceptable de ceux-ci. Les composés de formule I agissent en tant qu'inhibiteurs d'arginase et peuvent être utiles pour prévenir, traiter ou agir en tant qu'agent thérapeutique pour des maladies liées à l'arginase. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2021141751A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2021141751A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2021141751A13</originalsourceid><addsrcrecordid>eNrjZFBzDHL39HMMdlXw9PPwdPIM8Q8KVnD0c1HwdQ3x8HcJVvB3UwgNduVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRoaGJobmpoaOhsbEqQIAPZwkOw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ARGINASE INHIBITORS AND METHODS OF USE</title><source>esp@cenet</source><creator>LU, Min ; PALANI, Anandan ; PALTE, Rachel ; ACHAB, Abdelghani Abe ; SLOMAN, David ; CHILDERS, Matthew ; ZHANG, Hongjun ; PU, Qinglin ; FISCHER, Christian ; GATHIAKA, Symon ; LI, Derun</creator><creatorcontrib>LU, Min ; PALANI, Anandan ; PALTE, Rachel ; ACHAB, Abdelghani Abe ; SLOMAN, David ; CHILDERS, Matthew ; ZHANG, Hongjun ; PU, Qinglin ; FISCHER, Christian ; GATHIAKA, Symon ; LI, Derun</creatorcontrib><description>Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.
L'invention concerne des composés de formule I ou un sel pharmaceutiquement acceptable de ceux-ci. Les composés de formule I agissent en tant qu'inhibiteurs d'arginase et peuvent être utiles pour prévenir, traiter ou agir en tant qu'agent thérapeutique pour des maladies liées à l'arginase.</description><language>eng ; fre</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210715&DB=EPODOC&CC=WO&NR=2021141751A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210715&DB=EPODOC&CC=WO&NR=2021141751A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LU, Min</creatorcontrib><creatorcontrib>PALANI, Anandan</creatorcontrib><creatorcontrib>PALTE, Rachel</creatorcontrib><creatorcontrib>ACHAB, Abdelghani Abe</creatorcontrib><creatorcontrib>SLOMAN, David</creatorcontrib><creatorcontrib>CHILDERS, Matthew</creatorcontrib><creatorcontrib>ZHANG, Hongjun</creatorcontrib><creatorcontrib>PU, Qinglin</creatorcontrib><creatorcontrib>FISCHER, Christian</creatorcontrib><creatorcontrib>GATHIAKA, Symon</creatorcontrib><creatorcontrib>LI, Derun</creatorcontrib><title>ARGINASE INHIBITORS AND METHODS OF USE</title><description>Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.
L'invention concerne des composés de formule I ou un sel pharmaceutiquement acceptable de ceux-ci. Les composés de formule I agissent en tant qu'inhibiteurs d'arginase et peuvent être utiles pour prévenir, traiter ou agir en tant qu'agent thérapeutique pour des maladies liées à l'arginase.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBzDHL39HMMdlXw9PPwdPIM8Q8KVnD0c1HwdQ3x8HcJVvB3UwgNduVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRoaGJobmpoaOhsbEqQIAPZwkOw</recordid><startdate>20210715</startdate><enddate>20210715</enddate><creator>LU, Min</creator><creator>PALANI, Anandan</creator><creator>PALTE, Rachel</creator><creator>ACHAB, Abdelghani Abe</creator><creator>SLOMAN, David</creator><creator>CHILDERS, Matthew</creator><creator>ZHANG, Hongjun</creator><creator>PU, Qinglin</creator><creator>FISCHER, Christian</creator><creator>GATHIAKA, Symon</creator><creator>LI, Derun</creator><scope>EVB</scope></search><sort><creationdate>20210715</creationdate><title>ARGINASE INHIBITORS AND METHODS OF USE</title><author>LU, Min ; PALANI, Anandan ; PALTE, Rachel ; ACHAB, Abdelghani Abe ; SLOMAN, David ; CHILDERS, Matthew ; ZHANG, Hongjun ; PU, Qinglin ; FISCHER, Christian ; GATHIAKA, Symon ; LI, Derun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2021141751A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LU, Min</creatorcontrib><creatorcontrib>PALANI, Anandan</creatorcontrib><creatorcontrib>PALTE, Rachel</creatorcontrib><creatorcontrib>ACHAB, Abdelghani Abe</creatorcontrib><creatorcontrib>SLOMAN, David</creatorcontrib><creatorcontrib>CHILDERS, Matthew</creatorcontrib><creatorcontrib>ZHANG, Hongjun</creatorcontrib><creatorcontrib>PU, Qinglin</creatorcontrib><creatorcontrib>FISCHER, Christian</creatorcontrib><creatorcontrib>GATHIAKA, Symon</creatorcontrib><creatorcontrib>LI, Derun</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LU, Min</au><au>PALANI, Anandan</au><au>PALTE, Rachel</au><au>ACHAB, Abdelghani Abe</au><au>SLOMAN, David</au><au>CHILDERS, Matthew</au><au>ZHANG, Hongjun</au><au>PU, Qinglin</au><au>FISCHER, Christian</au><au>GATHIAKA, Symon</au><au>LI, Derun</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ARGINASE INHIBITORS AND METHODS OF USE</title><date>2021-07-15</date><risdate>2021</risdate><abstract>Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.
L'invention concerne des composés de formule I ou un sel pharmaceutiquement acceptable de ceux-ci. Les composés de formule I agissent en tant qu'inhibiteurs d'arginase et peuvent être utiles pour prévenir, traiter ou agir en tant qu'agent thérapeutique pour des maladies liées à l'arginase.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2021141751A1 |
| source | esp@cenet |
| subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ARGINASE INHIBITORS AND METHODS OF USE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A02%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LU,%20Min&rft.date=2021-07-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2021141751A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |